🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Primary Graft Dysfunction

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction NCT06853223Phase 21 site📍 San Francisco University of California, San Francisco · Tests: Maraviroc, Placebo Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction NCT07230886NA1 site📍 Toronto University Health Network, Toronto · Tests: Xo Port Organ Preservation System, Standard of Care - Ice packs Evaluation of Patients With Immune Function Abnormalities NCT00128973n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation NCT00552357n/a1 site📍 Philadelphia University of Pennsylvania
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy